Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 2Head & Neck 1Dermatologic 1

Conditions

Breast Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
technetium Tc 99m nanocolloid × Breast × Clear all
NCT04487912 2021-05-14

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

University Hospital, Ghent

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Unknown
30 enrolled
BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡